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The cytokine IL-15 is required for natural killer (NK) cell homeostasis; however, the intrinsic
mechanism governing this requirement remains unexplored. Here we identify the absolute
requirement for myeloid cell leukaemia sequence-1 (Mcl1) in the sustained survival of NK cells
in vivo. Mcl1 is highly expressed in NK cells and regulated by IL-15 in a dose-dependent
manner via STAT5 phosphorylation and subsequent binding to the 30-UTR of Mcl1. Specific
deletion of Mcl1 in NK cells results in the absolute loss of NK cells from all tissues owing to a
failure to antagonize pro-apoptotic proteins in the outer mitochondrial membrane. This NK
lymphopenia results in mice succumbing to multiorgan melanoma metastases, being
permissive to allogeneic transplantation and being resistant to toxic shock following poly-
microbial sepsis challenge. These results clearly demonstrate a non-redundant pathway
linking IL-15 to Mcl1 in the maintenance of NK cells and innate immune responses in vivo.
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I
nnate immune cells are responsible for pathogen detection,
rapid inflammation and priming of sterilizing immunity in
vertebrates. Innate lymphoid cells (ILCs) represent a diverse
family of bone marrow-derived lymphocytes whose development
depends on expression of the inhibitor of DNA-binding 2 (Id2)
and cytokine signalling via the gamma common (gC) receptor1.
ILCs are grouped into three subsets (ILC1–3) based on their
functions and dependency on specific transcription factors2. ILCs
do not express antigen receptors that are formed from
rearrangement of gene segments and, thus, rely primarily on
cytokines, not antigenic stimulation, to dictate their development,
activation and homeostasis. Natural killer (NK) cells are the most
prevalent ILC member (ILC1) being capable of spontaneous
cytokine, chemokine and lytic granule production upon
activation3. NK cell development takes place in the bone
marrow of adults and requires the pleiotropic cytokine,
interleukin-15 (IL-15)4,5 with high expression of the IL-15Rb
chain (CD122), an essential component of IL-15 signalling6
induced soon after commitment to the NK cell lineage7. IL-15-
responsive progenitors need to express dimers of IL-2Rb and the
common gamma chain (gc/IL-2Rg/CD132) and receptor
proximal kinases (Jak1/3) and Signal Transducer and Activator
of Transcription 5 (STAT5A/B) in order to survive, expand and
differentiate8.
Deletion of IL-15 or IL-15Ra in vivo largely blocks NK cell
development in mice; however, when IL-15 / or IL-15Ra /
progenitors were transferred into wild-type mice, NK cell
development was partially restored indicating a role for IL-15
and IL-15Ra ‘in trans’ expressed by non-haematopoietic cells9–13.
Both IL-2 and IL-15 utilize IL-2Rg/b heterodimers to transmit
proliferative and survival signals to NK cells and have been shown
to induce, enhance or maintain various members of the Bcl-2
family of anti-apoptotic proteins including Bcl-2, Bcl-xL and
Mcl-1 (refs 14–20). On the flipside, we previously proposed that
IL-15 regulates NK cell survival by inhibiting the activation of the
BH3-only protein Bim14. In this instance, Bim protein levels
dramatically increased in NK cells upon removal of IL-15
correlating with accelerated apoptosis. Stimulation of NK cells
with IL-15 induced activation of the PI3K and MAPK pathways
with phospho-Erk1/2 being responsible for Bim phosphorylation
and degradation, whereas IL-15 mediated activation of the PI3K
pathway was required to phosphorylate and inhibit Foxo3a (also
called FKHR-L1), a member of the family of Forkhead box class
O transcription factors known to induce Bim (Bcl2l11)
transcription21. The dependency on Bim for NK cell apoptosis
is evident by the resistance of Bim / NK cells to cell death in
the absence of IL-15 and their ability to persist when transferred
in IL15 / mice14. IL-7, IL-15 and IL-2 are known to promote
the survival of various T-cell subsets with upregulation of Mcl-1
observed following stimulation with these cytokines and deletion
ofMcl1 in differentiated T cells resulting in a significant reduction
in their numbers in vivo22,23, indicating a key requirement for
Mcl-1 in their steady-state survival. In addition to the well-
characterized outer mitochondrial membrane role of Mcl-1 in
antagonizing apoptotic proteins such as Bak, Bim and Noxa, it
was recently proposed that the inner amino-terminally truncated
isoform of Mcl-1 is imported into the mitochondrial matrix
where it participates in mitochondrial fusion, ATP production
and respiration24.
We hypothesized that IL-15-mediated signalling is essential for
NK cell homeostasis in vivo by primarily regulating the level of
the highly labile anti-apoptotic protein Mcl-1 in vivo. Using a
novel Mcl1-hCD4 mouse strain, whereby Cre-mediated deletion
of the Mcl1-coding sequence results in surface expression of
human CD4 (hCD4) under control of the Mcl1 regulatory
elements25,26, we conclusively demonstrate that Mcl1 expression
is directly regulated by IL-15 via STAT5 binding to its 30
untranslated region (UTR). The in vivo consequence of failing to
express Mcl1 in differentiated NK cells was explored using Ncr1
(NKp46)-mediated deletion (Ncr1-Cre) of Mcl1. NK cells are
completely absent from all tissues when both copies of Mcl1 are
deleted. This result in itself represents a milestone for the NK cell
field, as this is the first genetic model specifically and constantly
lacking NK cells. Our findings underline the non-redundant role
for Mcl1 in NK cell survival downstream of IL-2Rg/b and permit
the accurate investigation into the in vivo role of NK cells during
pathogenesis.
Results
NK cells express high Mcl1 levels throughout development. To
investigate cytokine-mediated survival in ILCs in vivo, we focused
on NK cells since their development is dependent on a single
growth factor (IL-15), their differentiation is well characterized
and they are abundant in lymphoid organs of mice3.
Peripheral NK cell maturation is defined by differential
expression of Mac-1, CD27 and KLRG1 with immature (Imm.)
NK cells being Mac-1CD27þKLRG1 , Mature 1 (M1) NK
cells being Mac-1þCD27þKLRG1 and Mature 2 (M2) being
Mac-1þCD27KLRG1þ (Fig. 1a)27–29. Measurement of mRNA
levels of Bcl-2 family members revealed that Mcl1 is highly
expressed in NK cells, and that this expression increases with
maturation (Fig. 1b and Supplementary Fig. 1). To visualize Mcl1
expression in vivo, we utilized a Mcl1-floxed-hCD4 mouse strain
(allele is termed Mcl1fl from herein). In this system, Cre-mediated
deletion of theMcl1-coding sequence results in surface expression
of hCD4 (hCD4) under control of the Mcl1 regulatory
elements25,26. This strain was bred to the Rosa26 Cre-ERT2
(CreERT2) mice to facilitate Mcl1 deletion in vivo. Treatment of
Mcl1fl/þCreERT2 mice with tamoxifen via oral gavage resulted in
stable expression of hCD4 (reporting on Mcl1 transcription) on
all haematopoietic cell types with the highest expression observed
on bone marrow progenitors (LSK cells; green) consistent with
previous data30, then CLPs (orange), while pre-pro NK cells
(Lin c-kit sca-1þflt3 IL-7Raþ ; red) and conventional NK
cells (blue) expressed slightly lower levels (Fig. 1c). In the
periphery, Mcl1 expression was found to increase as NK cells
matured with M2 NK cells (red) expressing clearly higher levels of
Mcl1 compared with M1 (blue) and Imm. (green) NK cells in the
spleen (Fig. 1d) and liver (Fig. 1e), consistent with our mRNA
data (Fig. 1b). We also verified Mcl1 expression in the TCR-b
NK1.1þCD49b hepatic resident NK cells (orange; Fig. 1e) since
their developmental origins and transcription factor requirements
are distinct from conventional NK cells31. TCR-
bNK1.1þCD49b hepatic resident NK cells expressed an
Mcl1 level equivalent to that of hepatic resident M1 NK cells
(Fig. 1e).
Mcl1 is induced by cC cytokines in a dose-dependent manner.
We next wanted to generate a model where Mcl1 was deleted
specifically in NK cells via Cre-mediated deletion. The Ncr1 gene
(encoding NKp46) is highly expressed in NK cells in all organs
and, importantly, Ncr1 is not expressed to any significant level on
other major immune cells. We investigated Mcl1 expression
specifically in NK cells by crossing the Mcl1fl-hCD4/þ mice with
the Ncr1-iCre (Ncr1-Cre) mice32. The strict requirement for IL-15
on NK cell development in vivo prompted us to investigate the
relationship between IL-15 and Mcl1 regulation in these
cells. Culturing NK cells (TCR-bNK1.1þNKp46þ ) from
Mcl1fl-hCD4/þ Ncr1-Cre mice in graded concentrations of IL-15
resulted in a robust dose-dependent increase in Mcl1 (hCD4)
expression (Fig. 2a). Western blot analysis of NK cell lysates
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confirmed that Mcl-1 and, to a lesser extent, Bcl-xL, but not Bcl-2,
were elevated following IL-15 stimulation in vitro (Fig. 2b) and
that these same proteins were degraded when IL-15 was
withdrawn from NK cells that had been cultivated in a high
concentration of IL-15 for 1 week (Fig. 2c). Since Bcl-xL was also
increased in NK cells following IL-15 stimulation (Fig. 2b), we
next determined the contribution of Bcl-xL to NK cell
development in vivo by conditional deletion of Bcl-x (BCL2L1)
in NK cells using the Bcl-x-loxP strain33. Bcl-xfl/flNcr1-Cre mice
presented a normal proportion and number of NK cells in all
organs examined indicating that Bcl-xL is not required for NK
cell development in vivo (Fig. 2d).
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Figure 1 | Mcl1 is expressed throughout NK cell development. (a) Peripheral NK cell subsets were sorted by flow cytometry from the spleen based on
TCR-b, NK1.1, CD122, NKp46, CD27, Mac-1 and KLRG1 expression (Imm.—green; M1—blue; M2—red) and (b) expression of Mcl1, Bcl2, Bcl-x (Bcl2l1), Bcl-w
(Bcl2l2) and A1 (Bcl2a1) mRNA was determined by qPCR and normalized to HPRT. Data represent the mean±s.d. of two independent experiments. (c)
Twelve-week-old Mcl1fl(loxp-hCD4)/þCreERT2 mice were treated with tamoxifen by oral gavage and Mcl-1 expression (reflected by surface hCD4) analysed
at 15 weeks by FACS in LSK cells (green), CLPs (orange), pre-pro NK cells (red) and conventional NK cells (blue) in the bone marrow. (d) Imm., M1 and M2
splenic NK cell subsets from Mcl1fl(loxp-hCD4)/þCreERT2 mice were analysed for Mcl1 (hCD4) expression by FACS. Black histograms in c,d represent
mononuclear cells from tamoxifen-treated Mcl1þ /þCreERT2 mice. Mcl-1fl(loxp-hCD4)/þCreERT2 mice were treated with tamoxifen by oral gavage. (d) Imm.,
M1 and M2 splenic NK cell subsets from Mcl1fl(loxp-hCD4)/þCreERT2 mice were analysed for Mcl1 (hCD4) expression by FACS. Mcl-1fl(loxp-hCD4)/þCreERT2
mice were treated with tamoxifen by oral gavage and (e) Imm. (green), M1 (blue) and M2 (red) and CD49b (orange) hepatic NK cell subsets were
analysed for Mcl-1 (hCD4) expression by FACS. Black histograms in c–f represent mononuclear cells from tamoxifen-treated Mcl1þ /þCreERT2 mice.
Data are representative of two independent experiments.
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Mcl1 is essential for the generation of NK cells in mice. Given
the abundant expression of Mcl-1 driven by IL-15 in NK cells, we
examined the importance of this pathway in vivo by deleting both
Mcl1 alleles specifically in NKp46þ cells using the Ncr1-Cremice.
The result was striking; Mcl-1fl/flNcr1-Creþ mice contained
essentially no NK cells (TCR-bNKp46þNK1.1þ or TCR-b
CD49bþNK1.1þ ) in all organs examined (Fig. 3a,b). The few
NK cells that remained in Mcl1fl/flNcr1-Cre mice were Imm.
(Fig. 3c). The Imm. stage of NK cell differentiation is the stage at
which Ncr1-mediated Cre expression begins32 and hence Mcl1
gene deletion is initiated (Supplementary Fig. 2); thus, the
appearance of only a very minor population of Imm. NK cells in
Mcl-1fl/flNcr1-Creþ mice confirms that the absence of Mcl-1 is
incompatible with NK cell viability.
Outer mitochondrial membrane Mcl-1 inhibits NK cell death.
Mcl-1 has been recently proposed to contribute to cellular bio-
genesis in the inner mitochondrial membrane in addition to its
known anti-apoptotic role in the outer membrane24. We next
examined the ability of Mcl-1 (able to access the outer
mitochondrial membrane and the mitochondrial matrix) and
an Mcl-1 variant, Mcl-1OM (expression restricted to the outer
mitochondrial membrane)24 in rescuing NK cell survival in the
absence of wild-type Mcl-1. To do this, Mcl-1fl/flNcr1-Cre LSK
cells were transduced in vitro with retrovirus encoding vector
alone, Mcl-1 or Mcl-1OM and all co-expressing green-fluorescent
protein; GFP; Fig. 4a). Total LSK cells were then cultured for 21
days in 50 ngml 1 IL-15 and analysed for NK cell generation.
Despite similar transduction efficiency to Mcl-1, Mcl-1fl/flNcr1-
Cre LSKs transduced with vector alone (GFP) failed to generate
NK cells, underlining the requirement of Mcl-1 for NK cell
genesis, even in high concentrations of IL-15. In contrast, ectopic
expression of either Mcl-1 or Mcl-1OM was equally efficient in
rescuing NK cell development from Mcl-1fl/flNcr1-Cre LSK cells
in vitro (Fig. 4a). NK cell development under these conditions
was robust and independent of Mcl-1 expression in the
mitochondrial matrix suggesting the primary defect following
loss of Mcl-1 in NK cells is the inability to antagonize the pro-
apoptotic BH3-only and BAX/BAK proteins and not in
mitochondrial fusion or cellular biogenesis. Collectively, these
results clearly indicate that Mcl-1 is the principle antagonist of
apoptosis in NK cells and are consistent with our in vitro
observation that Mcl-1 levels are proportional to NK cell viability
following IL-15 withdrawal (Fig. 2c)14.
IL-15 directly regulates Mcl1 via STAT5 binding the 30-UTR.
To understand how the dynamic regulation of Mcl1 in response
to IL-15 is achieved, we next investigated the molecular pathways
activated by IL-15 in NK cells. IL-15 stimulation of NK cells
resulted in the rapid induction of Jak1 and STAT5A/B phos-
phorylation that peaked between 30 and 60min (Fig. 4b). STAT5
is a transcription factor that dimerizes upon phosphorylation and
translocates to the nucleus where it can drive the expression of a
large number of genes via binding an evolutionarily conserved
TTC(T/C)N(G/A)GAA motif34,35. We identified a conserved
STAT motif in the promoter and a conserved STAT5 motif in 30-
UTR of Mcl1 (Fig. 4c). To determine whether STAT5 directly
bound to Mcl1 in NK cells, we cultivated NK cells in a high
concentration of IL-15 to induce STAT5 phosphorylation and
performed chromatin immunoprecipitation (ChIP) using STAT5
antiserum. NK cells not stimulated with IL-15 were used as a
negative control as these cells displayed negligible STAT5
phosphorylation with western blot. STAT5 ChIP confirmed a
robust enrichment of the 30-UTR sequence of Mcl1 but not the
promoter in NK cells stimulated with IL-15 compared with
untreated NK cells indicating that STAT5 directly binds the
30-UTR of Mcl1 (Fig. 4c). Enrichment of the well-characterized
STAT5 target gene Cish (cytokine-inducible SH2-containing
protein) was used as a positive control as this gene has multiple
TTC(T/C)N(G/A)GAA motifs in its promoter36 (Fig. 4c). Given
that IL-15 directly maintains NK cell viability by driving Mcl-1
expression via STAT5, we next determined whether the
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requirement for IL-15 could be overcome by transgenic
expression of Mcl1 in NK cells. NK cells from Vav-Mcl-1
transgenic (Mcl-1 Tg) mice37 displayed greatly enhanced Mcl-1
protein levels compared with littermate controls (Fig. 4d) and
when cultured in limiting concentrations of IL-15 Mcl-1 Tg NK
cell survival was 10- to 50-fold greater than control NK cells
(Fig. 4e). Taken together, these data identify Mcl1 as a STAT5
target gene in NK cells and highlight the direct link between IL-15
signalling and NK cell survival.
Absence of innate cytotoxicity in NK lymphopenic mice. NK
cells were the first ILCs described owing to their spontaneous
ability to kill target cells that had altered expression of major
histocompatibility complex (MHC)-I (non-self MHC-I or
reduced/absent MHC-I) and this role has since been extended to
the killing of cells expressing stress-induced activating
ligands38,39. NK cells are also potent producers of pro-
inflammatory cytokines, namely interferon (IFN)-g upon
pathogen encounter. Studying the in vivo role of NK cells has
largely relied on NK cells being depleted with anti-NK1.1
antibody since a mouse strain specifically lacking NK cells was,
until now, unavailable. We next examined some functional
consequences of the complete loss of NK cells in Mcl1fl/flNcr1-Cre
mice. Following injection with B16F10 murine melanoma cells
(lacking MHC-I but expressing DNAM-1 ligand, CD155), Mcl1fl/
flNcr1-Cre mice needed to be killed after 12 days because of acute
onset of respiratory distress. Post-mortem analysis revealed that
the lungs of these animals were overwhelmed with melanoma
metastases, whereas metastases were rarely observed in similarly
challenged control mice (Mcl1þ /þNcr1-Cre; Fig. 5a,b). B16F10 is
not thought to be a particularly metastatic variant of B16 and has
been classically used to measure experimental lung metastasis;
however, we discovered that at the low dose used, the tumour
cells metastasized extensively and were located in additional sites
in Mcl1fl/flNcr1-Cre mice. This included the liver, bone marrow,
kidney and lymph nodes, whereas metastases at these sites were
never observed in control mice (Fig. 5c,d).
Residual NK cell activity following whole-body g-irradiation is
associated with bone marrow allograft rejection40,41. Consistent
with the previous finding, C57BL/6 (H-2b) recipient mice lacking
NK cells (Mcl1fl/flNcr1-Cre) possessed significantly more splenic
monocytes and spleen colony-forming units (CFU-S) on day 8
post transplantation with allogeneic BALB/c (H-2d) bone
marrow cells compared with NK cell-proficient control
recipients (Mcl1þ /þNcr1-Cre; Fig. 5e,f). CFU-S counts are a
reflection of bone marrow engraftment and the fact that
recipients lacking NK cells possessed similar CFU-S counts
after allogeneic bone marrow transplantation as C57BL/6 mice
receiving syngeneic bone marrow (H-2b) demonstrates that Mcl-
1-dependent survival of NK cells is critical for the early clearance
of MHC-mismatched bone marrow and a contributing factor in
bone marrow transplant outcomes.
NK lymphopenia protects mice from lethal sepsis. Sepsis is a
systemic inflammatory response to bacterial infection resulting in
the death of over a million humans annually. Polymicrobial
sepsis induced by cecal ligation and puncture (CLP) is the
most common murine model of bacterial sepsis42. This model
induces a hyperinflammatory response by innate immune cells,
characterized by high levels of IL-6, tumour necrosis factor
and MCP-1 typically resulting in death within 48 h (ref. 43). To
investigate the contribution of NK cells in CLP-mediated
sepsis, we compared mice with varying degrees of NK cell
deficiency from includingMcl1fl/flNcr1-Cre (B0% NK cells), anti-
aasialoGM1-treated C57BL/6 (30–40% NK cells), anti-NK1.1-
treated C57BL/6 (B10% in NK cells) and control C57BL/6
Mcl1þ /þNcr1-Cre (100% NK cells; Fig. 6a). Strikingly, Mcl1fl/fl
Ncr1-Cre mice were resistant to toxic shock induced by CLP
compared with control mice, similarly mice depleted of NK cells
by antibody treatment (anti-NK1.1 and anti-aasialoGM1; Fig. 6a)
were also largely protected (Fig. 6b). The presence or absence of
NK cells had no bearing on the bacterial load with no differences
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these cells shown. Data in c are mean±s.e.m. of six mice of each genotype.
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in bacteria colony forming units observed in the blood at this
early time point (Fig. 6c). The protection offered by the absence
of NK cells was characterized by a significant reduction in IFN-g
and IL-6 protein levels in the serum 12 h following CLP
(Fig. 6d,e). This finding indicates that an NK cell-dependent
pro-inflammatory cytokine response contributes to the
lethality following CLP in mice and that even a 50% reduction
in NK cells is effective in reducing the incidence of death
due to septic shock.
Discussion
NK cells evolved before adaptive lymphocytes and lack the
somatically rearranged antigen receptors that control the
development and survival of B and T cells44,45. Here we
demonstrate conclusively that NK cells instead rely on a non-
redundant pathway for IL-15 in directly regulating the expression
of the anti-apoptotic protein Mcl-1 via STAT5 binding to the 30
UTR for their viability in vivo. Mcl-1 expression in NK cells
requires IL-15 and is tightly regulated suggesting that changes in
the levels of these cytokines will greatly impact on NK cell
homeostasis in vivo. IL-15 is derived from both parenchymal and
hematopoietic cells and plays an integral role in the homeostasis
of various T-cell subsets such as g/d T cells, NKT cells, CD8aa
T cells as well as innate lymphocytes46,47. A similar mechanism
of IL-15-dependent Mcl-1 regulation in these cell types is also
likely. Other members of the Bcl-2 family have been shown to be
upregulated in lymphocytes following stimulation with IL-15 and
proposed to antagonize the pro-apoptotic BH3-only and BAX/
BAK proteins to prevent cell death48,49. Our observation and
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those of others indicate that Bcl-2 family members in addition to
Mcl-1 are upregulated in NK cells by cytokines that stimulate gC
chain containing receptors; however, these apoptosis inhibitors
must function in synergy with Mcl-1 to promote NK cell
survival14,22. For example, while we found Bcl-xL to be
completely redundant in maintaining steady-state NK cell
survival, this is not to say that induction of Bcl-xL in NK cells
is irrelevant for NK cell survival during different circumstances
such as inflammation.
It is interesting that the requirement for Mcl-1 in NK cell
survival appears greater than that of STAT5, a major
transcriptional activator downstream of IL-15 signalling that we
found to bind the 30-UTR of Mcl1. In vivo deletion of STAT5
specifically in NK cells via the Ncr1-Cre transgene (using a
bacterial artificial chromosome approach) only resulted in three
to sixfold reduction in peripheral NK cell numbers in vivo50,
which is consistent with earlier germ-line deletion studies51 and
an order of magnitude less than the reduction in NK cells
observed in Mcl1fl/flNcr1-Cre mice (up to 100-fold reduction in
some organs). This suggests that STAT3, which is phosphorylated
following IL-15 stimulation in NK cells, may also contribute to
Mcl-1 expression in the absence of STAT5, as a similar pathway is
proposed to exist in various tumour cells52,53. STAT3
phosphorylation is also induced following stimulation of IL-
21R/gC heterodimers54 thus it will be interesting to investigate if
the synergy between IL-15 and IL-21 converge at the level of
STAT3 activation leading to Mcl1 expression.
We are only now beginning to understand the intrinsic
pathways required for NK cell homeostasis. Following upregula-
tion of Id2 in pre-pro NK cells7, expression of the IL-2/15Rb
(CD122) is acquired and NK cells become dependent on IL-15.
The near total loss of NK cells following Mcl1 deletion may
suggest that their dependency on Mcl-1 for survival is more
stringent than that of B and T cells, since specific deletion ofMcl1
using CD19-Cre (B-cell-specific) and Lck-Cre (T-cell-specific)
resulted in a less dramatic loss of these cell types in vivo22 than
what we observed for NK cells. It remains possible that this may
also reflect the efficiency of Cre expression from the respective
transgenes. The aforementioned conclusion would, however,
explain why transgenic Bcl-2 overexpression failed to rescue NK
cell development in gC / mice but could (partially) rescue T-cell
development in these animals55. Furthermore, specific deletion of
STAT5 in lymphoid progenitors via Rag1-Cre expression results
in an absence of Pro-B cells that can also be rescued by Bcl-2
overexpression56. In these ‘rescued’ STAT5-null Pro-B cells, Mcl-
1 protein was absent compared with STAT5-sufficient Pro-B cells
suggesting a role for STAT5 in directly inducing Mcl-1 in the B
lineage in response to IL-7 (ref. 56).
The fidelity and efficiency of Cre-expression in the Ncr1-iCre
strain is paramount to our success in generating an NK cell null
mouse model. This clear and sustained lack of innate effector
functions in Mcl1fl/flNcr1-Cre mice offers the most relevant
model to date in addressing the contribution of NK cells in
mammalian immune defense. This model does not require in vivo
administration of antibodies or diphtheria toxin to deplete NK
cells or affect additional cell types, caveats of all current
approaches4–6,57–59. Functionally, our results demonstrate that
NK cells are a rapid source of pro-inflammatory cytokines
following detection of bacteria in vivo contributing to septic shock
and are central to the clearance of cells lacking self-MHC-I
expression in vivo. Collectively, these findings unequivocally
demonstrate for the first time that induction of anti-apoptotic
Mcl-1 expression by IL-15 is required for the survival of NK cells
in vivo.
Methods
Mice. Mcl1-loxp-hCD4 (refs 25,26), Rosa26-CreERT2 (TaconicArtemis), Bcl-x-
loxp33 Rosa26-(loxP-stop-loxP)yfp60 Vav-Mcl1 Tg37 and Ncr1-iCre mice32 were
bred and maintained at the Walter and Eliza Hall of Medical Research. The Mcl-1-
loxp-hCD4, Rosa26-CreERT2, Vav-Mcl1 Tg and Rosa26-EYFP mice were generated
on a C57BL/6 background using C57BL/6-derived ES cells. The Ncr1-iCre mice
were generated on a mixed C57BL/6 129SV background using 129SV-derived ES
cells and then backcrossed with C57BL/6 mice for at least eight generations. The
relevant Animal Ethics and Experimentation Committees approved animal
experiments according to the guidelines of the National Health and Medical
Research Council Australia. Both female and male mice aged between 8 and 15
weeks of age were used in this study. Age and sex matching was performed for each
independent experiment.
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Figure 5 | Absence of innate cytotoxicity in NK lymphopenic mice.
Mcl1þ /þNcr1-Cre (negative control) and Mcl1fl/flNcr1-Cre mice were
injected i.v. with 40,000 B16F10 melanoma cells. On day 12, mice were
killed and peripheral organs analysed for B16F10 metastases.
(a) The frequency of lung metastases was enumerated. Data represent
mean±s.e.m. of five mice of each genotype. Student’s t-test; ***Po0.0001.
(b) Representative whole mounts of lungs are shown. (c) Representative
whole mounts of diseased bone marrow, liver, kidney and lymph nodes from
Mcl1fl/flNcr1-Cre mice are shown. (d) The frequency of mice with B16F10
metastases in additional organs was enumerated. (e) A total of 1.5 107
allogeneic (H-2d) bone marrow cells were transplanted into lethally
irradiated Mcl1fl/þNcr1-Cre and Mcl1fl/flNcr1-Cre (H-2b) recipients and
(e) splenic myeloid (Gr-1þ ) reconstitution analysed by flow cytometry.
(f) CFU-S were enumerated after 8 days. A total of 1.5 107 autologous
(H-2b) bone marrow cells (H-2b) were transplanted into lethally irradiated
Mcl1fl/þNcr1-Cre mice as a control. Data in e are representative and in f are
the mean±s.e.m. of three mice of each genotype. Student’s t-test;
*Po0.03.
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Flow cytometry and cell sorting. Antibodies specific for NK1.1 (PK136; 1:400),
Sca-1 (E13-161.7; 1:200), c-kit (2B8; 1:500), hCD4 (RPAT4; 1:100), Gr-1 (RB6-8C5;
1:500), CD244.2 (244F4; 1:200), CD19 (1D3; 1:500), CD3 (KT31.1; 1:500), CD122
(TM-b1; 1:200), NKp46 (29A1.4; 1:100), Flt3 (A2F10.1; 1:100), CD127 (A7R34;
1:200), CD11b (M1/70; 1:800), TCR-b (H57-5921; 1:500), CD45.2 (104; 1:500,
KLRG1 (2F1; 1:100), CD27 (LG.7F9; 1:200), H-2b (AF6-88.5.3.3; eBioscience;
1:100) H-2d (34-2-12; 1:100) and CD49b (DX5; 1:200 and HMa2; 1:200) were from
BD PharMingen unless stated otherwise. Single-cell suspensions were prepared by
forcing of organs through 70-mM sieves. Lymphocytes from the liver were isolated
by suspension in isotonic percoll (Amersham Pharmacia Biotech) and cen-
trifugation at 1,800 g. For flow cytometry, single-cell suspensions were stained with
the appropriate monoclonal antibody in phosphate-buffered saline (PBS) con-
taining 2% (vol/vol) fetal calf serum (FCS). FACS Verse, Fortessa and AriaII (BD
Biosciences) were used for cell sorting and analysis, with dead cells excluded by
propidium iodide staining. Depletion of differentiated cells was performed by
incubating bone marrow suspensions with a cocktail of rat monoclonal antibody
against CD3 (KT3), CD8 (53-6.7), CD19 (1D3), Ter119 (TER119), CD11b (M1/70)
and Ly6G (1A8). Supernatants from these hybridoma cultures were generated in
house, titrated on bone marrow suspensions and visualized with anti-rat FITC or
anti-rat Al700 to control for any variability in labelling efficiency over time.
Antibodies were added to the cocktail at the dilution found to give optimal labelling
by FACS, constituting 2–10% of the final cocktail volume. The bone marrow
suspension was then incubated with polyclonal sheep anti-rat IgG magnetic beads
at a ratio of eight beads per cell, and bead-bound cells magnetically depleted.
Remaining differentiated cells were visualized by staining with anti-rat Al700. All
single-cell suspensions were diluted in PBS before analysis and enumeration using
the Advia hematology analyzer (Siemens).
In vivo analysis of NK cells. Melanoma metastasis: 4 104 B16F10 melanoma
cells (perforin-sensitive, FasL- and TRAIL-insensitive, H-2b; ATCC) were injected
i.v. into mice and monitored for respiratory difficulty and weight loss. At 12 days,
mice were killed. Lymphoid organs, kidney, liver and lungs were harvested, fixed in
Bouin’s solution and B16F10 metastases counted61. Allogeneic bone marrow
transplants: 1.5 107 allogeneic (H-2d) and syngeneic (H-2b) total bone marrow
cells were injected i.v. into lethally irradiated mice (2 5.5 Gy). Eight days later,
mice were killed, and lymphoid organs harvested and analysed for H-2d
haematopoietic engraftment. Colony assays (CFU-S) were performed with 0.6%
agar and 2DMEþ 40% FCS. In all, 1 105 splenocytes per plate were added into
a tube containing equal concentrations of 2DME/FCS and Difco Bacto Agar. In
all, 100ml of GM-CSF made up at 100 ngml 1 was added to the plate. Plates were
incubated at 10% CO2 for 7 days and colonies were counted using a light
microscope. Colonies were classified as greater than 50 cells62,63. CLP was
performed at QIMR Berghofer Medical Research Institute. Briefly, mice were
anesthetized with isoflurane, the abdomen was shaved, disinfected using betadine
antiseptic spray and a midline incision made. The cecum was externalized with a
cotton bud and 75% was ligated and punctured once using a 25-gauge needle to
extrude a small amount of cecal content. The cecum was returned to the abdomen,
the peritoneal was closed via continuous suture and the skin was sealed using an
auto clip wound clip applier (Becton Dickinson). Buprenorphin (Reckitt Benckiser
Pharmaceutical) was applied at 0.05mg per kg body weight at the incision site for
postoperative analgesia64. NK cell depletion was performed by treating mice with
100 mg of purified antibody with anti-NK1.1 (PK136) or anti-aasialoGM1 antibody
(Wako Pure Chemical Industries) at day  3 and day 0 before CLP. Tamoxifen
oral gavage was performed as in refs 25,26.
In vitro NK cell assays. NK cell cultivation was performed in Iscove’s modified
Dulbecco’s medium supplemented with 10% (vol/vol) FCS plus gentamycin
(50 ngml 1; Sigma) and 40 ngml 1 recombinant hIL-15 (Peprotech). NK cells
cocultured (1 105 of each) in vitro with various doses of hIL-15 (Peprotech) for 5
days. Mcl-1 induction studies were performed by culturing purified Mcl1fl-hCD4/þ
Ncr1-Cre NK cells in hIL-15 (Peprotech) in 96-well, flat-bottomed plates. Live and
dead cells were discriminated by staining with propidium iodide. Bone marrow
LSK cell transduction was performed using retrovirus packaged in 293T cells.
Briefly, 10-cm tissue culture plates containing 80% confluent 293T cells were
treated with chloroquine (25mM) for 30min at 37 C before transfection with
plasmids encoding eco-MLV (0.2 mgml 1), gag-pol (0.3 mgml 1) and either GFP,
Mcl-1 or Mcl-1OM (ref. 14) (1 mgml 1) using CaCl2 (20mM) and HBSS (2 )24.
LSKs were transduced with a combination of RetroNectin (Takara) and spin
inoculation. Twelve well non-tissue culture plates were coated for 12 h with
RetroNectin (4mg cm 2 in PBS) at 4 C before blocking with PBS containing 2%
(wt/vol) bovine serum albumin (BSA) at 25 C. Viral supernatant (2ml) was added
and plates were then centrifuged for 2 h at 37 C and 1,200 g. LSKs were cultured
for 48 h in IL-15 (50 ngml 1) at 2 106 cells per ml. Polybrene (2.5 mgml 1) was
added to these cultures, and the cultures added to each virus coated well from
above after the viral supernatant was removed. Cells were then cultured for 12 h at
37 C. Fresh wells were then coated with 2ml viral supernatant as above, and the
LSK cultures transferred to these wells for 12 h at 37 C. Cultures were transferred
to tissue culture-treated plates after this second round of transduction, and
infection efficiency was determined using flow cytometry of GFP expression.
Quantitative PCR and STAT5 ChIP. Total RNA from 3 105 Imm. M1 and M2
NK cells were purified using RNeasy mini columns (Qiagen). SuperScript II reverse
transcriptase (Roche) was used for first-strand cDNA synthesis according to the
manufacturer’s instructions. Quantitative PCR was performed using Sensimix
SYBR HI-ROX (Bioline) and the Bio Rad CFX384 detection system and software
(Bio Rad). Primers used (Mcl1, Bcl2, Bcl-x (Bcl2l1), Bcl-w (Bcl2l2) and A1 (Bcla1),
Puma (Bbc3), Noxa (Pmaip1), Bim (Bcl211)) have been described65. The relative
expression of each gene was normalized to Hprt. For STAT5 ChIP, 1.5 107
in vitro expanded splenic NK cells were cultured in IL-15 (40 ngml 1) or media
alone for 5 h. NK cells were then crosslinked for 10min in presence of 1%
paraformaldehyde (Sigma) in PBS then lysed (1% SDSþ 1mM EDTAþ proteases
inhibitors). Crosslinked DNA was sonicated with the Branson sonifier 250
(Branson). Lysates were incubated overnight with 10 mg of Pan human/mouse
Stat5a/b antibody (R&D). In all, 100 ml of Protein G Dynabeads (Invitrogen) were
added and incubated for 2 h at 4 C under gentle rotation. Unbound chromatin was
removed using a series of five washes (low salt, high salt, liCL and 2xTE). Following
elution, bound chromatin was reverse cross-linked and subjected to phenol/
chloroform immunoprecipitation. Recovered DNA was resuspended in TE buffer
and enrichment for specific region of the genome was measured with real-time
PCR using the primers described (Supplementary Table 1). Raw Ct values are
shown in Supplementary Table 2.
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Figure 6 | NK lymphopenia protects mice from lethal sepsis. CLP was performed on mice lacking NK cells (Mcl1fl/flNcr1-Cre) or with reduced numbers of
NK cells (anti-NK1.1 or anti-aasialoGM1 antibody treated). (a) NK cell frequencies were enumerated in the blood of the indicated mice on the
day of CLP. Student’s t-tests using the Sidak–Bonferroni method; **Po0.01; *Po0.03. (b) Kaplan–Meier survival curve following CLP-induced septic shock.
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Immunoblotting. Protein extracts were prepared in RIPA buffer (300mM NaCl,
2% IGEPAL CA-630, 1% deoxycholic acid, 0.2% SDS, 100mM Tris–Hcl pH 8.0)
and 30 mg of protein was loaded into NuPAGE 10% Bis-Tris gels. Western blotting
was performed according to the standard procedures. Blots were probed with the
following antibodies: Mcl-1 (1:1,000 clone 19C4-15, WEHI mAb lab); Bcl-2
((1:500) clone 7, BD Biosciences); Bcl-xL ((1:1,000) polyclonal, BD Biosciences);
pY-STAT5 (Tyr694; 1:1,000 Millipore), pY-Jak1 (1:1,000 1022/1023; Invitrogen),
Erk1/2 (1:1,000 Cell Signaling), Bim (1:2,000 polyclonal, Enzo Life Sciences); and
b-actin (1:2,000 clone AC-74, Sigma). Uncropped Immunoblots are displayed in
Supplementary Fig. 3.
Statistical analysis. A standard Student’s t-test with two-tailed distributions for
two samples with equal variance was used for statistical analysis. P values are
provided. In Fig. 6b significance of survival differences were determined using
Mantel–Cox test, whereas for Fig. 6c,e,f, t-tests using the Sidak–Bonferroni method
were performed.
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